Skip to main content
. 2018 Nov 22;8(12):122. doi: 10.1038/s41408-018-0152-x

Fig. 2. Changes of driver mutation variant allele frequency (VAF) over study period.

Fig. 2

The VAF of the JAK2V617F, MPLW515x and CALR driver mutation was measured in samples collected at baseline (BL) and at the latest available follow-up (FU) in patients receiving ruxolitinib (a) and hydroxyurea (b)